Court orders Boston Scientific to complete $275M acquisition

Boston Scientific Corp. could be forced to go through with a $275 million acquisition that the Marlborough-based medical device giant had abandoned following a fraud investigation. Boston Scientific (NYSE: BSX) struck a deal in 2017 to purchase California medical device company Channel Medsystems Inc., and then called off the deal last year after finding out that one Channel’s executives had falsified paperwork, including portions of Channel’s FDA application for its fir st product. But a Delaware…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news